![Geoffrey von Maltzahn](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Geoffrey von Maltzahn
Founder at
Profile
Geoffrey von Maltzahn was the founder of Seres Therapeutics, Inc. (2010, Chief Technology Officer), Axcella Health, Inc. (2008, Vice President-Discovery), Indigo Ag, Inc. (2013, Chief Innovation Officer & Director), Kaleido Biosciences, Inc. (2015, Director), Generate Biomedicines, Inc. (2018, Director), Mirai Bio (2021, Chief Executive Officer), Tessera Therapeutics, Inc. (2018, Chairman), and Quotient Therapeutics Ltd. (2022, Chairman).
Dr. von Maltzahn is also the founder of Resonance Therapeutics, Sienna Biopharmaceuticals, Inc. Current job: General Partner at Flagship Pioneering, Inc. (2009 - present).
Former jobs include President, Chief Executive Officer & Director at Cobalt Biomedicine, Inc., Independent Director at Sana Biotechnology, Inc. (2019 - 2021), and Vice President-Corporate Development at Essentient, Inc. Education includes undergraduate and doctorate degrees from Massachusetts Institute of Technology and a graduate degree from the University of California San Diego.
Latest news about Geoffrey von Maltzahn
Geoffrey von Maltzahn active positions
| Companies | Position | Start |
|---|---|---|
Resonance Therapeutics
 Resonance Therapeutics Medical/Nursing ServicesHealth Services Develops clinical applications for nano-rods and technologies to improve the efficacy of cancer therapeutics | Founder | 2009-09-16 |
Indigo Ag, Inc.
 Indigo Ag, Inc. Develops biological and digital technologies | Founder | 2012-12-31 |
Flagship Pioneering, Inc.
 Flagship Pioneering, Inc. Investment ManagersFinance Flagship Pioneering invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, life science tools & diagnostics, bioenergy and cleantech sectors. It provides financing for seed, early and later-stage capital requirements. The firm makes co-investments and also acts as a lead investor. | Private Equity Investor | 2008-12-31 |
Generate Biomedicines, Inc.
 Generate Biomedicines, Inc. Develops therapeutics and novel medicines | Founder | 2017-12-31 |
Tessera Therapeutics, Inc.
 Tessera Therapeutics, Inc. Operates as a biotechnology company that writes therapeutic messages into the genome to treat diseases | Founder | 2017-12-31 |
Former positions of Geoffrey von Maltzahn
| Companies | Position | End |
|---|---|---|
| KALEIDO BIOSCIENCES, INC. | Founder | 2022-03-14 |
| SANA BIOTECHNOLOGY, INC. | Director/Board Member | 2021-08-31 |
Cobalt Biomedicine, Inc.
 Cobalt Biomedicine, Inc. Engages in developing therapeutic based drugs | Chief Executive Officer | 2019-01-31 |
Essentient, Inc.
 Essentient, Inc. Develops transforming global nutrition | Corporate Officer/Principal | 2014-02-16 |
| ░░░░ ░░░░░░░ | ░░░░░░░ | ░░░░░░░░░░ |
Training of Geoffrey von Maltzahn
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 14 |
|---|---|
Flagship Pioneering, Inc.
Flagship Pioneering, Inc. Investment ManagersFinance Flagship Pioneering invests in companies located across the globe. The firm targets companies operating in the fields of therapeutics, life science tools & diagnostics, bioenergy and cleantech sectors. It provides financing for seed, early and later-stage capital requirements. The firm makes co-investments and also acts as a lead investor. | Finance |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
University of California San Diego
 University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Resonance Therapeutics
Resonance Therapeutics Medical/Nursing ServicesHealth Services Develops clinical applications for nano-rods and technologies to improve the efficacy of cancer therapeutics | Health Services |
Essentient, Inc.
Essentient, Inc. Develops transforming global nutrition | |
Seres Therapeutics, Inc.
 Seres Therapeutics, Inc. Develops novel treatments for diseases related to the human microbiome | |
Axcella Health, Inc.
 Axcella Health, Inc. Provides first-in-class precision therapeutic solutions to diseases with a focus on restoring amino acid biology | |
Indigo Ag, Inc.
Indigo Ag, Inc. Develops biological and digital technologies | |
Kaleido Biosciences, Inc.
 Kaleido Biosciences, Inc. Operates as clinical-stage biotechnology company which develops therapeutic products to systematically shape the micro biome | |
Sienna Biopharmaceuticals, Inc.
 Sienna Biopharmaceuticals, Inc. Operates as a biopharmaceutical company that develops and manufactures drugs for treating inflammatory skin disorders | |
Sana Biotechnology, Inc.
 Sana Biotechnology, Inc. Operates as a biotechnological company which creates and delivers engineered cells as medicine for patients | |
Cobalt Biomedicine, Inc.
Cobalt Biomedicine, Inc. Engages in developing therapeutic based drugs | |
Tessera Therapeutics, Inc.
Tessera Therapeutics, Inc. Operates as a biotechnology company that writes therapeutic messages into the genome to treat diseases | |
Generate Biomedicines, Inc.
Generate Biomedicines, Inc. Develops therapeutics and novel medicines |
- Stock Market
- Insiders
- Geoffrey von Maltzahn
